Invivyd IVVD
NASDAQ IVVD
$0.67 +0.04 (+5.55%)
As of: Oct 21, 2026 · 11:40 AM EDT

Invivyd (IVVD) EBITDA Margin (2024 - 2025)

Updated

Invivyd (IVVD) posted EBITDA Margin of -72.10% for Q4 2025, up 59.20 percentage points from -131.30% a year earlier and up 10.73 percentage points from the prior quarter.

Analysis

Invivyd (IVVD) EBITDA Margin (2024 - 2025) Analysis & Trends

For FY2025, Invivyd's EBITDA Margin came in at -102.58%, up 588.44 percentage points from FY2024.

  • In prior years, Invivyd's EBITDA Margin was -691.03% in FY2024.
  • On a year-over-year basis, EBITDA Margin has increased in each of the last three quarters.
  • According to Business Quant data, EBITDA Margin for the three prior quarters was -82.82% (Q3 2025), -126.50% (Q2 2025) and -146.99% (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn 53.49%
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn 35.95%
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn 49.01%
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn 6.02%
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn -
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn 33.11%
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn 46.01%
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn -124.26%
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn 39.16%
10 Invivyd 215.94 Mn -290.70 Mn 13.01 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -72.10%
Sep 30, 2025 -82.82%
Jun 30, 2025 -126.50%
Mar 31, 2025 -146.99%
Dec 31, 2024 -131.30%
Sep 30, 2024 -668.59%
Jun 30, 2024 -2,169.57%
API Access

Invivyd EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=IVVD&period=max&api_key=YOUR_API_KEY